Towards a Best Practice Approach in PBPK Modeling: Case Example of Developing a Unified Efavirenz Model Accounting for Induction of CYPs 3A4 and 2B6

por Ke, A, Barter, Z, Rowland‐Yeo, K, Almond, L
Publicado 2016

A PBPK Model to Predict Disposition of CYP3A-Metabolized Drugs in Pregnant Women: Verification and Discerning the Site of CYP3A Induction

por Ke, A B, Nallani, S C, Zhao, P, Rostami-Hodjegan, A, Unadkat, J D
Publicado 2012

Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling

por Zhang, P-F, Li, K-S, Shen, Y-h, Gao, P-T, Dong, Z-R, Cai, J-B, Zhang, C, Huang, X-Y, Tian, M-X, Hu, Z-Q, Gao, D-M, Fan, J, Ke, A-W, Shi, G-M
Publicado 2016